Seeing Is Believing
Currently out of the existing stock ratings of James Mainwaring, 5 are a BUY (62.5%), 3 are a HOLD (37.5%).
Analyst James Mainwaring, currently employed at ATLANTIC EQUITIES, carries an average stock price target met ratio of 58.33% that have a potential upside of 11.22% achieved within 274 days.
James Mainwaring’s has documented 14 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDT, Medtronic PLC at 01-Jun-2022.
Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 4/12/2022. The price target of $135 was fulfilled within 127 days with a profit of $12.97 (10.63%) receiving and performance score of 0.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Jul-2026
$135
$-10.97 (-7.52%)
$180
Buy Since 06-Apr-2026
$148
$2.03 (1.39%)
$140
Buy Since 26-Feb-2026
$150
$4.03 (2.76%)
$145
Buy Since 02-Jun-2026
$155
$18.99 (13.96%)
$145
Buy Since 24-May-2023
$155
$9.03 (6.19%)
$165
What Year was the first public recommendation made by James Mainwaring?